Human serum albumin–polyethylenimine nanoparticles for gene deliveryStephanie Rhaese, Klaus Langer, Jörg Kreuter et al.|Journal of Controlled Release|2003Cited by 175
The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, ThailandMarcia L. Kalish, Saladin Osmanov, Nancy L. Young et al.|AIDS|1995Cited by 168
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitroArmin Bender, Helga Rübsamen‐Waigmann, Hagen von Briesen et al.|Antimicrobial Agents and Chemotherapy|1996Cited by 155
Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these virusesManuel Grez, Helga Rübsamen‐Waigmann, Ursula Dietrich et al.|Journal of Virology|1994Cited by 150
Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug TargetingVolker Schäfer, Helga Rübsamen‐Waigmann, Hagen von Briesen et al.|Pharmaceutical Research|1992Cited by 142